Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2011-07-12
2011-07-12
Yu, Misook (Department: 1643)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C435S328000, C435S332000, C530S350000, C530S388100, C530S388200, C530S391300
Reexamination Certificate
active
07977461
ABSTRACT:
The present invention provides an antibody which has the following features, its active fragment, or a derivative thereof:a) It specifically binds to human platelet membrane glycoprotein VI (GPVI);b) The function to activate a platelet and/or the function to induce a thrombocytopenia in vivo are low; andc) It at least partially depletes GPVI on the platelet membrane by contacting with a platelet.
REFERENCES:
patent: 2002/0141992 (2002-10-01), Nieswandt
patent: 2009/0041783 (2009-02-01), Takayama et al.
patent: 1 369 128 (2003-12-01), None
patent: 1 538 165 (2005-06-01), None
patent: 1 647 596 (2006-04-01), None
patent: 11-004694 (1999-01-01), None
patent: 11-243955 (1999-09-01), None
patent: WO 90/07861 (1990-07-01), None
patent: WO 91/09967 (1991-07-01), None
patent: WO 00/68377 (2000-11-01), None
patent: WO 01/16321 (2001-03-01), None
patent: WO 02/080968 (2002-10-01), None
patent: WO 03/008454 (2003-01-01), None
patent: WO 03/054020 (2003-07-01), None
patent: WO 2005/007800 (2005-01-01), None
Clemetson et al (JBC, 274(41):29019-29024, 1999).
Immunology, Infection, and Immunity (Edited by Pier et al, p. 49, 2004).
Mariuzza et al. (Annu. Rev. Biophys. Biophys. Chem. 1987; 16: 139-159).
Gussow et al. (Methods in Enzymology. 1991; 203: 99-121).
Greenspan et al. (Nature Biotechnology. 1999; 7: 936-937).
Xia et al (Mol. Imm., 47:1808-1816, 2010).
Rudikoff et al (Proc. Natl. Acad. Sci. USA 1982 vol. 79: p. 1979-1983).
MacCallum et al. (J. Mol. Biol. Oct. 11, 1996; 262 (5): 732-745).
Holm et al. (Mol. Immunol. Feb. 2007; 44 (6): 1075-1084).
Sugiyama et al (Blood (USA), 69(6):1712-1720, 1987).
Takayama et al (JCI, 118(5):1795-1795, 2008).
Supplementary European Search Report dated Dec. 30, 2008, in corresponding European Application No. 0674241.6, 6 pages.
Lecut et al., “Human platelet glycoprotein VI function is antagonized by monoclonal antibody-derived Fab fragments,” Journal of Thrombosis and Haemostasis, Dec. 1, 2003, 1(12):2653-2662.
McKean et al., “Mechanisms of antibody diversity: Multiple genes encode structurally related mouse κ variable regions,” Proc. Natl. Acad. Sci. USA, Aug. 1978, 75(8):3913-3917.
Moroi et al., “Platelet glycoprotein VI: its structure and function,” Thrombosis Research, Jan. 1, 2004, 114(4):221-233.
Nieswandt et al., “Long-term Antithrombotic Protection by In Vivo Depletion of Platelet Glycoprotein VI in Mice,” J. Exp. Med., Feb. 19, 2001, 193(4):459-469.
Schulte et al., “Evidence for Two Distinct Epitopes within Collagen for Activation of Murine Platelets,” J. Biol. Chem., Jan. 5, 2001, 276(1):364-368.
Smethurst et al., “Identification of the primary collagen-binding surface on human glycoprotein VI by site-directed mutagenesis and by a blocking phage antibody,” Blood, Feb. 1, 2004, 103(3):903-911.
Weigert et al., “Rearrangement of genetic information may produce immunoglobulin diversity,” Nature, Dec. 21, 1978, 276 (5690):785-790.
Amersdorfer et al., “Molecular Characterization of Murine Humoral Immune Response to Botulinum Neurotoxin Type A Binding Domain as Assessed by Using Phage Antibody Libraries,” Infection and Immunity, Sep. 1997, 65(9):3743-3752.
Stark et al., “Antibodies that are Specific for a Single Amino Acid Interchange in a Protein Epitope Use Structurally Distinct Variable Regions,” J. Exp. Med., Sep. 1991, 174:613-624.
International Search Report mailed May 16, 2006, in PCT/JP2006/301818, 2 pages.
Gardiner et al., “Regulation of platelet membrane levels of glycoprotein VI by a platelet-derived metalloproteinase,” Blood, 2004, 104(12):3611-3617.
Lecut et al., “Identification of residues within human glycoprotein VI involved in the binding to collagen,” J. Biol. Chem., 2004, 279(50):52293-52299.
Stephens et al., “Platelet activation induces metalloproteinase-dependent GP VI cleavage to down-regulate platelet reactivity to collagen,” Blood, Jan. 2005, 105(1):186-191.
Takayama, Hiroshi, “Ko Kesshoban Ryoho,” Kessen to Junkan, Mar. 10, 2005, 13(1):56-59.
Cortez-Retamozo et al., “Efficient Cancer Therapy with a Nanobody-Based Conjugate,” Cancer Research, Apr. 15, 2004, 64:2853-2857.
Orita et al., “A novel therapeutic approach for thrombocytopenia by minibody agonist of the thrombopoietin receptor,” Blood, Jan. 15, 2005, 105(2):562-566.
Davies et al., “Affinity improvement of single antibody VH domains: residues in all three hypervariable regions affect antigen binding,” Immunotechnology, Sep. 1, 1996, 2(3):169-179.
Gruener et al., “Relative antithrombotic effect of soluble GPVI dimmer compared with anti-GPVI antibodies in mice,” Blood, American Society of Hematology, Feb. 15, 2005, 105(4):1492-1499.
Holt et al., “Domain antibodies: proteins for therapy,” Trends in Biotechnology, Nov. 1, 2003, 21(11):484-490.
Furusako Shoji
Honda Motoyasu
Hosaka Yoshitaka
Hotta Yumi
Kawahara Tetsushi
Duffy Brad
Foley & Lardner LLP
Mochida Pharmaceutical Co. Ltd.
Yu Misook
LandOfFree
Anti-platelet membrane glycoprotein VI monoclonal antibody does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-platelet membrane glycoprotein VI monoclonal antibody, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-platelet membrane glycoprotein VI monoclonal antibody will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2675213